lqirupdwlrq - disease models & mechanisms · han4.13 cells. there is mixed glandular and...

7
Chemotherapy Drug Dose 1 (mg/kg) Dose 2 (mg/kg) Ca Folinate 100 50 Oxaliplatin 5 2.5 Irinotecan 50 25 5-Fluorouracil 50 25 A C B Supplementary Figures Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information Disease Models & Mechanisms • Supplementary information

Upload: others

Post on 31-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

Chemotherapy Drug Dose 1 (mg/kg) Dose 2 (mg/kg)

Ca Folinate 100 50

Oxaliplatin 5 2.5

Irinotecan 50 25

5-Fluorouracil 50 25

A

C

B

Supplementary Figures

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n

Page 2: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

Supplementary Figure 1. Murine FOLIFIRINOX Dosing

(A) Kaplan-meier survival curve after two doses of FOLFIRINOX (n = 5 per experimental group). Fifty

percent of mice given the higher dose died within two weeks after the first dose of drug. No mice died

with the reduced dose. (B) All mice lost progressive weight starting after the first dose of FOLFIRINOX.

(C) FOLFIRINOX dosing regimens.

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n

Page 3: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

Supplementary Figure 2. Cytokeratin Staining of Pancreatitis-Related Ductal Metaplasia

Pan-cytokeratin staining of orthotopic tumor and surrounding pancreas with H&E co-staining. The tumor

mass (left side of image) stains uniformly positive for cytokeratin, as expected. Fibrosis surrounding the

tumor is delineated (dashed black line). Pancreas tissue is located on the right of the image, which is

inflamed with evidence of ductal metaplasia by cytokeratin staining (dashed red line).

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n

Page 4: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

10 Days

16 Days

30 Days

A

B0 100 200 300 400 500 µm

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n

Page 5: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

Supplementary Figure 3. Characterization of Fibrosis Progression in Orthotopic Tumors Over

Time

(A) Collagen proportional area (CPA) quantification of tumor fibrosis at 10, 16 and 30 days after

implantation (n = 4 per experimental group, error bars represented as mean ± SD). Fibrosis significantly

increases up to postoperative day 16, after which collagen deposition relative to tumor mass appears to

stabilize as the CPA level for postoperative day 30 is similar to day 16. (B) Representative Sirius Red

staining of orthotopic tumors extracted at 10, 16, and 30 days after implantation. Although the

orthotopic model has a robust fibrotic response on the tumor periphery, intercalation of stromal cells

and collagen deposition occurs throughout the tumor bed as shown by the images. * p < 0.05, ** p <

0.01.

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n

Page 6: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n

Page 7: LQIRUPDWLRQ - Disease Models & Mechanisms · Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the tumor mass. Pancreatitis is present distal

Supplementary Figure 4. Phenotypic Features of Orthotopic and Heterotopic Tumors Using

Han4.13 Cells

(A) Representative H&E and Sirius Red staining of an orthotopic tumor two weeks after implantation of

104 Han4.13 cells. There is mixed glandular and sarcomatoid morphologies distributed throughout the

tumor mass. Pancreatitis is present distal to the tumor along the length of the main pancreatic duct

(zoomed image). (B) Representative H&E and Sirius Red staining of a heterotopic tumor two weeks

after implantation of 104 Han4.13 cells. Similar to Hy15549 tumors of the flank, there is a dense fibrotic

response.

Disease Models & Mechanisms 11: doi:10.1242/dmm.034793: Supplementary information

Dis

ease

Mo

dels

& M

echa

nism

s •

Sup

plem

enta

ry in

form

atio

n